Avery Dennison (AVY) SVP reports new RSU grants and performance-based vesting
Rhea-AI Filing Summary
Avery Dennison senior vice president and chief strategy and development officer Danny Gilad Allouche reported a series of equity compensation transactions. He was granted 2,183 restricted stock units from a 2026 RSU award and 3,157 performance units from a 2026 PU award, each representing the right to receive one share of common stock if vesting conditions are met.
Multiple earlier performance-based MSU and PU awards vested on the same date at 56% to 96% of target based on absolute and relative total stockholder return and economic value added metrics, as described in the footnotes. These vestings resulted in common shares being acquired indirectly through a trust at a reference price of $194.78 per share, with several smaller tax-withholding dispositions reported under code F to satisfy exercise price or tax obligations.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 1,447 shares
Net Buy
17 txns
Insider
Allouche Danny Gilad
Role
SVP & CSDO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | 2026 RSU Award | 2,183 | $0.00 | $0.00 |
| Grant/Award | 2026 PU Award | 3,157 | $0.00 | $0.00 |
| Exercise | 2022 MSU Award | 466 | $0.00 | $0.00 |
| Exercise | 2023 MSU Award | 352 | $0.00 | $0.00 |
| Exercise | 2024 MSU Award | 236 | $0.00 | $0.00 |
| Exercise | 2025 MSU Award | 590 | $0.00 | $0.00 |
| Exercise | 2023 PU Award | 791 | $0.00 | $0.00 |
| Exercise | Common Stock | 466 | $194.78 | $91K |
| Exercise Price or Tax Liability | Common Stock | 202 | $194.78 | $39K |
| Exercise | Common Stock | 352 | $194.78 | $69K |
| Exercise Price or Tax Liability | Common Stock | 142 | $194.78 | $28K |
| Exercise | Common Stock | 236 | $194.78 | $46K |
| Exercise Price or Tax Liability | Common Stock | 91 | $194.78 | $18K |
| Exercise | Common Stock | 590 | $194.78 | $115K |
| Exercise Price or Tax Liability | Common Stock | 239 | $194.78 | $47K |
| Exercise | Common Stock | 791 | $194.78 | $154K |
| Exercise Price or Tax Liability | Common Stock | 314 | $194.78 | $61K |
Holdings After Transaction:
2026 RSU Award — 2,183 shares (Direct);
2026 PU Award — 3,157 shares (Direct);
2022 MSU Award — 0 shares (Direct);
2023 MSU Award — 348 shares (Direct);
2024 MSU Award — 495 shares (Direct);
2025 MSU Award — 1,847 shares (Direct);
2023 PU Award — 0 shares (Direct);
Common Stock — 23,153 shares (Indirect, Trust)
Footnotes (7)
- F1. Restricted stock units (RSUs) vest 25% on each of the first, second, third and fourth anniversaries of the grant date. Each RSU represents a contingent right to receive one share of common stock.
- F2. Performance units (PUs) vest, at the end of fiscal year 2028, provided certain performance objectives are met as determined by the Compensation Committee in February 2029. Each PU represents a contingent right to receive one share of common stock.
- F3. Shares reflect the vesting of the fourth tranche of MSUs granted in February 2022 at 92% of target based on our absolute total stockholder return in excess of 10% during the 2022-2025 performance period, plus dividend equivalents accrued during the period.
- F4. Shares reflect the vesting of the third tranche of MSUs granted in March 2023 at 96% of target based on our absolute total stockholder return during the 2023-2025 performance period, plus dividend equivalents accrued during the period.
- F5. Shares reflect the vesting of the second tranche of MSUs granted in March 2024 at 92% of target based on our absolute total stockholder return during the 2024-2025 performance period, plus dividend equivalents accrued during the period.
- F6. Shares reflect the vesting of the first tranche of MSUs granted in March 2025 at 94% of target based on our absolute total stockholder return during the 2025 performance period, plus dividend equivalents accrued during the period.
- F7. Shares reflect the vesting of PUs granted in March 2023 at 56% of target, based 50% on our cumulative economic value added of 0% of target and 50% on our relative total stockholder return of 112% of target.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did Avery Dennison (AVY) report for Danny Gilad Allouche?
Danny Gilad Allouche reported grants of new 2026 restricted stock units and performance units, plus vesting and exercises of prior MSU and PU awards. Resulting common shares were acquired indirectly through a trust, with some shares withheld to cover exercise price or tax obligations.
How many new equity awards did the Avery Dennison (AVY) executive receive?
He received 2,183 restricted stock units from a 2026 RSU award and 3,157 performance units from a 2026 PU award. Each unit represents a contingent right to one Avery Dennison common share, subject to time-based or performance-based vesting conditions described in the filing footnotes.
What performance results affected the vesting of Avery Dennison (AVY) MSU awards?
MSU tranches granted in 2022, 2023, 2024, and 2025 vested between 92% and 96% of target. Vesting levels were based on absolute total stockholder return over specified performance periods, plus dividend equivalents accrued during those periods, as detailed in the transaction footnotes.
How did performance units (PUs) for Avery Dennison (AVY) vest for the executive?
PUs granted in March 2023 vested at 56% of target, based half on cumulative economic value added at 0% of target and half on relative total stockholder return at 112% of target. Each PU converts into one common share upon vesting under these performance results.
How are the new Avery Dennison (AVY) 2026 RSU and PU awards scheduled to vest?
The 2026 RSU award vests in four equal 25% installments on each of the first four anniversaries of the grant date. The 2026 PU award vests at the end of fiscal 2028, subject to performance objectives set and certified by the Compensation Committee in February 2029.